Showing results (1-10 of 73) with videos related to
Sort By:
Pageof 8
Trends in Molecular Medicine|March 7, 2002
Medicinal chemistry and therapeutic potential of CpG DNASudhir Agrawal, Ekambar R KandimallaImmuno-Oncology Technology|June 27, 2022
Intratumoural immunotherapy: activation of nucleic acid sensing pattern recognition receptorsSudhir Agrawal, Ekambar R KandimallaAnnals of the New York Academy of Sciences|January 31, 2004
Modulation of Toll-like Receptor 9 Responses through Synthetic Immunostimulatory Motifs of DNASudhir Agrawal, Ekambar R KandimallaCurrent Protocols in Nucleic Acid Chemistry|April 23, 2008
Chemistry of CpG DNAEkambar R Kandimalla, Sudhir AgrawalNature Biotechnology|December 8, 2004
Role of Toll-like receptors in antisense and siRNA [corrected]Sudhir Agrawal, Ekambar R KandimallaMethods in Molecular Biology (Clifton, N.J.)|July 13, 2011
Synthesis, purification, and characterization of oligoribonucleotides that act as agonists of TLR7 and/or TLR8Tao Lan, Ekambar R KandimallaCurrent Opinion in Molecular Therapeutics|June 5, 2002
Towards optimal design of second-generation immunomodulatory oligonucleotidesEkambar R Kandimalla, Dong Yu, Sudhir AgrawalMethods in Molecular Biology (Clifton, N.J.)|July 13, 2011
Synthesis, purification, and characterization of immune-modulatory oligodeoxynucleotides that act as agonists of Toll-like receptor 9Mallikarjuna Reddy Putta, Dong Yu, Ekambar R KandimallaInternational Immunopharmacology|April 15, 2005
Oligodeoxynucleotides containing synthetic immunostimulatory motifs augment potent Th1 immune responses to HBsAg in miceYukui Li, Ekambar R Kandimalla, Dong Yu, et al.The Journal of Allergy and Clinical Immunology|June 22, 2007
Oral administration of a synthetic agonist of Toll-like receptor 9 potently modulates peanut-induced allergy in miceFu-Gang Zhu, Ekambar R Kandimalla, Dong Yu, et al.Pageof 8